A phase II trial of an oral CDK 4/6 inhibitor, PD0332991, in advanced breast cancer.
Angela DeMichele
Consultant or Advisory Role - Pfizer
Research Funding - Pfizer
Amy Sanders Clark
No relevant relationships to disclose
Daniel Heitjan
No relevant relationships to disclose
Sophia Randolph
Employment or Leadership Position - Pfizer
Maryann Gallagher
No relevant relationships to disclose
Priti Lal
No relevant relationships to disclose
Michael D Feldman
No relevant relationships to disclose
Paul J. Zhang
No relevant relationships to disclose
Allison Schnader
No relevant relationships to disclose
Kelly Zafman
No relevant relationships to disclose
Susan M. Domchek
No relevant relationships to disclose
Keerthi Gogineni
No relevant relationships to disclose
Stephen Michael Keefe
Research Funding - Pfizer
Kevin R. Fox
Consultant or Advisory Role - Genomic Health; Novartis
Peter J. O'Dwyer
Research Funding - Pfizer